AskBio Inc. · 5 days ago
VP, Product Development
Durham, NC
Full-time
Onsite
Director/Executive
12+ years expAskBio Inc. is a fully integrated gene therapy company dedicated to developing life-saving medicines and changing lives. The VP, Product Development will lead research and discovery efforts to drive innovation and advance the preclinical pipeline, working closely with cross-functional teams to transform scientific and technological innovation into therapeutic products.
BiopharmaBiotechnologyHealth CareManufacturingMedicalMedical Device
Responsibilities
Stay at the forefront of and drive innovation in genetic medicine, including gene therapy and gene editing
Lead and oversee research and discovery activities (target validation, in vitro and in vivo pharmacology) required to advance programs through candidate nomination with speed and quality
Collaborate with translational medicine and regulatory teams on IND‑enabling stages. Contribute to the preparation and submission of regulatory documents
Prioritize and execute pipeline programs including timely allocation of resourcing and capabilities to prioritized programs and budget oversight
Efficiently manage a team of scientists and researchers, fostering a culture of clarity and innovation through collaboration and scientific excellence
Empower, coach and guide the development of next-generation leaders
Partner closely with Delivery (viral and non-viral), Informatics/AI/ML and CMC to incorporate new platform technologies into products and bolster innovation
Partner closely with Clinical Development and Business Strategy teams to enable end-to-end Research and Development strategy and clarify Target Product Profile
Acting as part of the AskBio R&D Leadership Team and a member of the Research and Discovery Committee, contribute to AskBio’s R&D strategy, pipeline project prioritization and project execution
Serve as a technical and strategic leader on external partnership discussions and execution, playing a critical role in due diligence and fostering external innovation
Qualification
Required
PhD in Molecular Biology, Virology, Genetics, or a related field with 12+ years of related experience (this can include a combination of post-doc/academic, industry, and similar experience)
Proven track record of advancing gene therapy candidates from early research through preclinical development
Experience in pre-IND and IND filing
Proven ability to think strategically, identify scientific opportunities, and translate them into actionable research plans
Outstanding leadership skills in building and fostering high-performing R&D teams in a fast-paced, innovation-driven environment
Strong knowledge of regulatory and quality requirements in the gene therapy/editing field
Excellent collaboration mindset and skills, with the ability to work effectively across cross-functional teams
Demonstrated ability to establish and maintain external collaborations with academic institutions, industry partners, and key opinion leaders
Excellent communication skills, both verbal and written, with the ability to effectively present scientific findings to diverse audiences
Preferred
Strong passion and knowledge in developing cutting-edge platform technologies (viral- and non-viral delivery) and incorporating them into product discovery and development
Experience in applying AI to target identification and product design
Company
AskBio Inc.
AskBio Inc., a wholly owned and independently operated subsidiary of Bayer AG, is a fully integrated gene therapy company dedicated to developing life-saving medicines and changing lives.
501-1000 employees
H1B Sponsorship
AskBio Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (1)
2023 (4)
2022 (8)
2021 (3)
2020 (3)
Funding
Current Stage
Late StageTotal Funding
$241.76MKey Investors
Scottish Enterprise
2020-10-26Acquired
2020-09-02Grant· $2.66M
2019-04-11Private Equity· $235M
Leadership Team
S
Samuel Hopkins
Sr. Vice President, Therapeutics
Mansuo L Shannon
Board Member
Recent News
BioWorld Financial Watch
2026-01-16
Company data provided by crunchbase